Bio-Thera Solutions, (688177) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

688177 Bio-Thera Solutions,

Watchlist

18.78
-0.01-0.05%

Post Market Jan 16 15:00 CST

7.78BMarket Cap-20.59P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Bio-Thera Solutions Partners With Tabuk Pharmaceuticals to Commercialize Bat2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
ReutersDec 24, 2024 07:01 ET
Is Bio-Thera Solutions (SHSE:688177) A Risky Investment?
Simply Wall StDec 19, 2024 19:07 ET
Bio-Thera Solutions Grants Costa Rican Pharma Firm Right to Market Autoimmune Drug
MT NewswiresDec 17, 2024 01:07 ET
Express News | Bio-Thera Solutions Expands Partnership With Steincares in Latam With Addition of a Third Biosimilar to Partnership
ReutersDec 16, 2024 07:00 ET
Bio-Thera Solutions Receives $10 Million Payment Related to Licensing Deal
MT NewswiresNov 14, 2024 02:55 ET
Bio-Thera Solutions, Ltd.'s (SHSE:688177) Last Week's 8.7% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
Simply Wall StNov 4, 2024 20:43 ET

Comments

Moomoo AI

Mar 14, 2024 17:28

Despite weak revenue forecasts, Bio-Thera Solutions' high P/S ratio shows investor optimism. However, revenue growth could impact share price. With a weak revenue outlook, share price may decline, affecting P/S figures. Investors should be cautious.

Bio-Thera Solutions, Ltd.'s (SHSE:688177) 26% Price Boost Is Out Of Tune With Revenues

Moomoo AI

Jan 26, 2024 19:13

Despite a high P/S ratio, the company's growth rates are limited. Investors may face disappointment if the P/S falls in line with recent growth rates. The high P/S ratio may not be justified given recent performance.

Bio-Thera Solutions, Ltd.'s (SHSE:688177) Price Is Out Of Tune With Revenues

Moomoo AI

Nov 13, 2023 18:22

Bio-Thera Solutions maintains strong finances but loss at EBIT level and fall in revenue indicate future risks. The company's financial developments need monitoring due to these risks.

Is Bio-Thera Solutions (SHSE:688177) Using Debt In A Risky Way?

Heat List

Overall

No Data